ReviewCancers2024

Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Kremena Petrova Trichkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.